Medicinova (MNOV) Interest Coverage Ratio (2010 - 2026)
Medicinova (MNOV) posted quarterly Interest Coverage Ratio of 1030.8 for Q4 2025, down 16088.65% year-over-year from N/an in Q4 2024, and down 5217.94% quarter-over-quarter from 19.38 in Q3 2025.
Medicinova (MNOV) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Medicinova (MNOV) has reported Interest Coverage Ratio for 16 consecutive years, with 1030.8 the latest figure, recorded in Q4 2025.
- In Q4 2025, Interest Coverage Ratio fell 16088.65% year-over-year to 1030.8; the TTM figure through Dec 2025 stood at 4427.67 (down 17365.69% YoY), while the FY2025 annual figure was 0.16, up 99.35% from the prior year.
- Interest Coverage Ratio retreated to 1030.8 in Q4 2025 per MNOV's latest filing, from 19.38 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.03 in Q4 2023 and bottomed at 1030.8 in Q4 2025.
- Historically, Interest Coverage Ratio has averaged 69.2 across 5 years, with a median of 8.25 in 2025.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio sank 126858.54% — and 2025, when it soared 79.52%.
- Medicinova's Interest Coverage Ratio stood at 4.97 in 2021, then rose by 11.42% to 4.4 in 2022, then surged by 99.32% to 0.03 in 2023, then sank by 21217.68% to 6.37 in 2024, then sank by 16088.65% to 1030.8 in 2025.
- Business Quant data shows MNOV's Interest Coverage Ratio at 1030.8 in Q4 2025, 19.38 in Q3 2025, and 11.03 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | 1.42 |
| 10 | Medicinova | 67.92 Mn | 67.92 Mn | 317,759.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -21.02 |
| Dec 31, 2025 | -1,030.80 |
| Sep 30, 2025 | -19.38 |
| Jun 30, 2025 | -11.03 |
| Mar 31, 2025 | -8.25 |
| Dec 31, 2024 | -6.37 |
| Sep 30, 2024 | -46.79 |
| Jun 30, 2024 | -5.47 |
| Mar 31, 2024 | -40.27 |
| Dec 31, 2023 | -0.03 |
| Sep 30, 2023 | -1.48 |
| Jun 30, 2023 | -15.98 |
| Mar 31, 2023 | -3.89 |
| Sep 30, 2022 | -4.40 |
| Jun 30, 2022 | -22.56 |
| Mar 31, 2022 | -16.51 |
| Dec 31, 2021 | -4.97 |
| Sep 30, 2021 | -3.25 |
| Jun 30, 2021 | -70.02 |
| Mar 31, 2021 | -3.27 |